|
Volumn 117, Issue 2, 2002, Pages 306-314
|
Treatment of infants with lymphoblastic leukaemia: Results of the UK Infant protocols 1987-1999
|
Author keywords
Infant; Leukaemia; Lymphoblastic; Prognosis; Treatment
|
Indexed keywords
ASPARAGINASE;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DAUNORUBICIN;
DEXAMETHASONE;
ETOPOSIDE;
MERCAPTOPURINE;
METHOTREXATE;
MITOXANTRONE;
PREDNISOLONE;
TIOGUANINE;
VINCRISTINE;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ANTIGEN EXPRESSION;
ARTICLE;
BONE MARROW TRANSPLANTATION;
BRAIN PROTECTION;
CANCER CHEMOTHERAPY;
CANCER REGRESSION;
CANCER SURVIVAL;
CENTRAL NERVOUS SYSTEM;
CONTROLLED STUDY;
CYTOGENETICS;
FEBRILE NEUTROPENIA;
FEMALE;
GASTROINTESTINAL TOXICITY;
HIGH RISK POPULATION;
HUMAN;
INFANT;
INFANT DISEASE;
LEUKOCYTE COUNT;
MAJOR CLINICAL STUDY;
MALE;
MULTIVARIATE ANALYSIS;
PRIORITY JOURNAL;
PROGNOSIS;
SURVIVAL TIME;
UNITED KINGDOM;
AGE FACTORS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BONE MARROW TRANSPLANTATION;
CENTRAL NERVOUS SYSTEM DISEASES;
CHI-SQUARE DISTRIBUTION;
DISEASE-FREE SURVIVAL;
FEMALE;
GREAT BRITAIN;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INFANT;
INFANT, NEWBORN;
INJECTIONS, SPINAL;
LEUKEMIA, LYMPHOCYTIC, ACUTE, L1;
LEUKOCYTE COUNT;
MALE;
METHOTREXATE;
PROGNOSIS;
REMISSION INDUCTION;
SURVIVAL RATE;
|
EID: 0036243081
PISSN: 00071048
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2141.2002.03442.x Document Type: Article |
Times cited : (61)
|
References (25)
|